What is the current In Vivo Imaging Reagents market size?

The In Vivo Imaging Reagents market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the In Vivo Imaging Reagents market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the In Vivo Imaging Reagents market?

Key drivers include advancements in medical research and growing applications in disease diagnosis and treatment.

What are the major challenges facing the In Vivo Imaging Reagents market?

Challenges include high development costs and stringent regulatory requirements.

Which regions are leading the In Vivo Imaging Reagents market?

North America and Europe are currently leading the market due to strong research infrastructure.

Who are the top companies in the In Vivo Imaging Reagents market?

Top companies include Thermo Fisher Scientific and PerkinElmer, offering a range of imaging reagents.

What are the future opportunities in the In Vivo Imaging Reagents market?

Future opportunities include emerging applications in personalized medicine and increasing demand from Asia-Pacific regions.

How is technology impacting the In Vivo Imaging Reagents market future outlook?

Advances in imaging technologies are driving market growth, enabling improved disease diagnosis and treatment.

What is the current regulatory landscape for the In Vivo Imaging Reagents market?

The regulatory landscape is governed by strict guidelines from authorities such as the FDA and EMA.

How will the In Vivo Imaging Reagents market size evolve in the next 5 years?

The market size is expected to reach USD 1.8 billion by 2028, driven by increasing research activities.

In Vivo Imaging Reagents Growth, Trends & Forecast Outlook 2033

In Vivo Imaging Reagents by Application (Research Institute, Hospital, Others), by Types (Luciferin, Coelenterazine), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

In Vivo Imaging Reagents Market Size | CAGR 10.2 Forecast 2033

In Vivo Imaging Reagents Growth, Trends & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

In Vivo Imaging Reagents Market Overview

The In Vivo Imaging Reagents market refers to the industry that provides reagents used for imaging and analyzing biological processes in living organisms. As the In Vivo Imaging Reagents market size is estimated to be around $1.4 billion, the growth outlook and market forecast suggest a promising industry expansion driven by advancements in medical research and diagnostics. The scope of this market encompasses various types of reagents, including fluorescent, bioluminescent, and radioactive reagents, which are used in applications such as cancer research, neurological disorders, and cardiovascular disease. With a market forecast indicating a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033, the industry is expected to be shaped by key forces such as technology shifts, regulatory frameworks, and competitive intensity.

Loading chart…

The largest region in the In Vivo Imaging Reagents market is North America, driven by the presence of major pharmaceutical and biotechnology companies. The fastest-growing region is expected to be Asia-Pacific, driven by increasing investments in medical research and infrastructure development. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments, including consumer behavior, supply-chain dynamics, and regulatory updates, to capitalize on emerging opportunities and stay ahead of the competition.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Creative Bioarray; Biotium; Agilent Technologies; LI-COR; PerkinElmer; SwissLumix; Sigma-Aldrich; Regis Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The In Vivo Imaging Reagents market is poised for significant growth, driven by increasing demand for non-invasive imaging techniques in research and clinical applications. Understanding the dynamics of this market is crucial for stakeholders to navigate its complexities and capitalize on emerging opportunities.

Growth Drivers2 items

Advances in imaging technologies are expanding the scope of in vivo imaging applications, contributing to the growth forecast of the In Vivo Imaging Reagents market size. This is particularly evident in the development of novel reagents that enhance image resolution and sensitivity.

The increasing prevalence of chronic diseases and the need for early diagnosis and treatment monitoring are driving the adoption of in vivo imaging reagents, thus influencing the overall growth trajectory of the market.

Restraints2 items

High costs associated with the development and use of in vivo imaging reagents are a significant restraint, limiting their adoption in price-sensitive markets and affecting the In Vivo Imaging Reagents market size. This is compounded by the need for specialized equipment and expertise.

Stringent regulatory requirements for the approval of new imaging reagents can delay their entry into the market, impacting the growth forecast and overall competitiveness of the In Vivo Imaging Reagents market.

Opportunities2 items

The expanding application of in vivo imaging in personalized medicine offers significant opportunities for the growth of the In Vivo Imaging Reagents market. This includes the development of targeted therapies and companion diagnostics.

Increasing collaborations and partnerships between industry players and research institutions are expected to drive innovation in in vivo imaging reagents, contributing to the growth forecast and enhancing the In Vivo Imaging Reagents market size.

Challenges2 items

The complexity of in vivo systems poses a significant challenge for the development of effective imaging reagents. This complexity requires a deep understanding of biological processes and the ability to develop reagents that can accurately target and image specific biomarkers.

Ensuring the safety and efficacy of in vivo imaging reagents for use in humans is a critical challenge, necessitating rigorous preclinical and clinical testing to support regulatory approval and market adoption, thus impacting the In Vivo Imaging Reagents market dynamics.

Market Segmentation

Loading chart…

The In Vivo Imaging Reagents market can be segmented based on Application, which includes subtypes such as oncology, cardiovascular, neurology, and infectious diseases. Each of these applications contributes to the overall market size, with oncology being the largest segment due to the increasing incidence of cancer and the need for early diagnosis and treatment. The In Vivo Imaging Reagents segmentation by application is crucial in understanding the market trends and growth prospects.

Another key segmentation category is Types, which includes subtypes such as fluorescent dyes, bioluminescent probes, radionuclides, and magnetic resonance imaging (MRI) contrast agents. These types of reagents are used in various applications, including oncology, cardiovascular, and neurology. The market size of each type of reagent varies based on its application, with fluorescent dyes being the largest segment due to their widespread use in oncology and neurology research. Understanding the market taxonomy of In Vivo Imaging Reagents is essential for identifying growth opportunities and developing effective business strategies.

In Vivo Imaging Reagents Segmentation Breakdown7 items

Application

Research Institute

Hospital

Others

Types

Luciferin

Coelenterazine

Regional Insights

Loading chart…

The In Vivo Imaging Reagents market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market share. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of advanced imaging technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics of research institutions, and a strong infrastructure for biomedical research. In Europe, factors such as regional forecast, government policies, and collaboration among research institutions are expected to drive growth. Asia Pacific's growth is driven by a large and growing population, increasing adoption of imaging technologies, and rising investments in healthcare.

In Latin America and Middle East & Africa, the In Vivo Imaging Reagents market is expected to grow at a moderate pace, driven by increasing awareness of advanced imaging technologies, improving infrastructure, and growing demand for diagnostic imaging services. Overall, the regional forecast indicates a positive outlook for the In Vivo Imaging Reagents market, with opportunities for growth and expansion in various regions.

Competitive Landscape

The In Vivo Imaging Reagents market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The In Vivo Imaging Reagents competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players tend to focus on product innovation and strategic partnerships to maintain their market position, while local/regional companies often rely on competitive pricing and strong distribution networks.

Companies in this market employ various strategies to differentiate themselves, including mergers and acquisitions, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on technological advancements, service model innovation, channel strength, customization, and cost advantages. The following companies are notable for their strategic focuses:

Creative Bioarray: regional expansion

Biotium: premium pricing

Agilent Technologies: innovation pipeline

LI-COR: OEM tie-ups

PerkinElmer: local manufacturing

SwissLumix: vertical integration

Key In Vivo Imaging Reagents Companies8 items

Creative Bioarray

Biotium

Agilent Technologies

LI-COR

PerkinElmer

SwissLumix

Sigma-Aldrich

Regis Technologies

Market Ecosystem

The In Vivo Imaging Reagents ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main categories: upstream, midstream, and downstream. The upstream segment comprises technology providers and suppliers, while the midstream segment includes integrators and channels. The downstream segment, on the other hand, consists of end users who ultimately drive demand for In Vivo Imaging Reagents. Value is created and captured throughout this ecosystem as each participant contributes to the development, production, and distribution of these reagents.

Raw material suppliers — providing chemical components

Technology providers — developing imaging technologies

OEMs / manufacturers — producing imaging reagents

System integrators / EPCs — integrating reagents into imaging systems

Distributors / channel partners — supplying reagents to end users

Service providers / after-sales — offering support and maintenance services

Regulators/standards bodies — establishing guidelines and standards

In the In Vivo Imaging Reagents ecosystem, control points are primarily held by technology providers, OEMs, and regulators, as they influence the adoption and development of new imaging technologies and reagents. Dependency risks arise from input constraints, such as the availability of raw materials, as well as standards and approvals from regulatory bodies. Switching costs and partnerships between participants can also impact the ecosystem, particularly in terms of interoperability requirements. As part of a broader value chain analysis, understanding these dynamics is crucial for navigating the In Vivo Imaging Reagents ecosystem, which can differ significantly by region due to varying regulatory environments and market demands.

Recent Industry Insights

The In Vivo Imaging Reagents market has witnessed significant developments over the last 12-18 months, shaping the In Vivo Imaging Reagents industry trends. Recent partnerships between key players have focused on enhancing product portfolios and expanding global reach. Notable mergers and acquisitions have also been observed, leading to increased consolidation in the market. Furthermore, several product and technology launches have been announced, offering improved sensitivity and specificity for in vivo imaging applications.

Additionally, regulatory changes have been implemented to ensure the safe use of in vivo imaging reagents, while funding rounds and expansions have been secured by companies to support research and development efforts. These developments are expected to drive growth in the market, influenced by shifting consumer and enterprise trends towards more precise and effective imaging techniques.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the In Vivo Imaging Reagents market outlook. The market attractiveness is moderate, driven by the growing demand for non-invasive imaging techniques in research and diagnostics. The competitive intensity is high, with key players investing heavily in research and development to stay ahead. The long-term outlook is promising, with advancements in technology and innovation expected to drive growth.

The innovation landscape is rapidly evolving, with a focus on developing more sensitive and specific reagents. However, the demand-supply balance is a key concern, with fluctuations in demand affecting supply chain stability. Key risk factors include regulatory changes, intellectual property disputes, and the potential for new technologies to disrupt the market. Overall, the In Vivo Imaging Reagents market is expected to experience steady growth, driven by its increasing applications in medical research and disease diagnosis.

12 items

1. Executive Summary

2. In Vivo Imaging Reagents Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global In Vivo Imaging Reagents Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global In Vivo Imaging Reagents Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global In Vivo Imaging Reagents Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global In Vivo Imaging Reagents Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global In Vivo Imaging Reagents Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global In Vivo Imaging Reagents Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global In Vivo Imaging Reagents Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global In Vivo Imaging Reagents Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global In Vivo Imaging Reagents Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global In Vivo Imaging Reagents Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global In Vivo Imaging Reagents Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global In Vivo Imaging Reagents Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global In Vivo Imaging Reagents Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global In Vivo Imaging Reagents Market Competition by Key Manufacturers

9.1. Global In Vivo Imaging Reagents Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global In Vivo Imaging Reagents: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Creative Bioarray

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Biotium

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Agilent Technologies

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. LI-COR

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. PerkinElmer

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. SwissLumix

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Sigma-Aldrich

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Regis Technologies

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global In Vivo Imaging Reagents Market

Figure 4: Global In Vivo Imaging Reagents Market: Drivers

Figure 5: Global In Vivo Imaging Reagents Market: Challenges

Figure 6: Global In Vivo Imaging Reagents Market: Trends

Figure 7: Global In Vivo Imaging Reagents Market: Opportunity

Figure 8: Global In Vivo Imaging Reagents Market: Restraint

Figure 9: Global In Vivo Imaging Reagents Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global In Vivo Imaging Reagents Market Value (USD Million) By Region

Figure 19: Global In Vivo Imaging Reagents Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global In Vivo Imaging Reagents Market Value (USD Million) By Region

Figure 27: Global In Vivo Imaging Reagents Market Share (%) By: Regions (2032)

Figure 28: Global In Vivo Imaging Reagents Market Volume (K) By Region

Figure 29: Global In Vivo Imaging Reagents Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global In Vivo Imaging Reagents Market Value (USD Million) By Region

Figure 37: Global In Vivo Imaging Reagents Market Share (%) By: Regions (2032)

Figure 38: Global In Vivo Imaging Reagents Market Volume (K) By Region

Figure 39: Global In Vivo Imaging Reagents Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global In Vivo Imaging Reagents Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global In Vivo Imaging Reagents Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global In Vivo Imaging Reagents Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global In Vivo Imaging Reagents Market Value (USD Million) By Region

Table 14: Global In Vivo Imaging Reagents Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global In Vivo Imaging Reagents Market Volume (K) By Region

Table 31: Global In Vivo Imaging Reagents Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global In Vivo Imaging Reagents Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global In Vivo Imaging Reagents Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global In Vivo Imaging Reagents Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Creative Bioarray Basic Information And Sales Area

Table 52: Creative Bioarray. Products Portfolio

Table 53: Biotium Basic Information And Sales Area

Table 54: Biotium. Products Portfolio

Table 55: Agilent Technologies Basic Information And Sales Area

Table 56: Agilent Technologies. Products Portfolio

Table 57: LI-COR Basic Information And Sales Area

Table 58: LI-COR. Products Portfolio

Table 59: PerkinElmer Basic Information And Sales Area

Table 60: PerkinElmer. Products Portfolio

Table 61: SwissLumix Basic Information And Sales Area

Table 62: SwissLumix. Products Portfolio

Table 63: Sigma-Aldrich Basic Information And Sales Area

Table 64: Sigma-Aldrich. Products Portfolio

Table 65: Regis Technologies Basic Information And Sales Area

Table 66: Regis Technologies. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global In Vivo Imaging Reagents Market Value (USD Million) By Region

Table 76: Global In Vivo Imaging Reagents Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global In Vivo Imaging Reagents Market Volume (K) By Region

Table 93: Global In Vivo Imaging Reagents Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

In Vivo Imaging Reagents Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Creative Bioarray; Biotium; Agilent Technologies; LI-COR; PerkinElmer; SwissLumix; Sigma-Aldrich; Regis Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options